American Heart Journal

Papers
(The H4-Index of American Heart Journal is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms161
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study160
Table of Contents92
Table of Contents82
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial72
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease68
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study64
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism51
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF50
Editorial Board48
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial47
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes40
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network39
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network39
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function36
Information for Readers36
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e35
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial34
Information for Readers34
The trial to assess chelation therapy 2 (TACT2): Rationale and design34
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer33
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study33
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections33
Physician responses to apple watch-detected irregular rhythm alerts32
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States32
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings29
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients28
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER28
Cardiac auscultation skills among medical trainees28
0.21873593330383